Common Contracts
5 similar Bond Hedge Amendment Letter Agreement contracts by Globus Medical Inc
BOND HEDGE AMENDMENT LETTER AGREEMENTBond Hedge Amendment Letter Agreement • November 7th, 2023 • Globus Medical Inc • Surgical & medical instruments & apparatus • New York
THIS BOND HEDGE AMENDMENT LETTER AGREEMENT (this “Letter Agreement”), dated as of September 1, 2023, is entered into among Royal Bank of Canada (the “Dealer”), NuVasive, Inc. (the “Counterparty”) and Globus Medical, Inc. (the “Parent”).
BOND HEDGE AMENDMENT LETTER AGREEMENTBond Hedge Amendment Letter Agreement • November 7th, 2023 • Globus Medical Inc • Surgical & medical instruments & apparatus • New York
THIS BOND HEDGE AMENDMENT LETTER AGREEMENT (this “Letter Agreement”), dated as of September 1, 2023, is entered into among Morgan Stanley & Co. International plc (the “Dealer”), NuVasive, Inc. (the “Counterparty”) and Globus Medical, Inc. (the “Parent”).
BOND HEDGE AMENDMENT LETTER AGREEMENTBond Hedge Amendment Letter Agreement • November 7th, 2023 • Globus Medical Inc • Surgical & medical instruments & apparatus • New York
THIS BOND HEDGE AMENDMENT LETTER AGREEMENT (this “Letter Agreement”), dated as of September 1, 2023, is entered into among The Bank of Nova Scotia (the “Dealer”), NuVasive, Inc. (the “Counterparty”) and Globus Medical, Inc. (the “Parent”).
BOND HEDGE AMENDMENT LETTER AGREEMENTBond Hedge Amendment Letter Agreement • November 7th, 2023 • Globus Medical Inc • Surgical & medical instruments & apparatus • New York
THIS BOND HEDGE AMENDMENT LETTER AGREEMENT (this “Letter Agreement”), dated as of September 1, 2023, is entered into among JPMorgan Chase Bank, National Association, New York Branch (the “Dealer”), NuVasive, Inc. (the “Counterparty”) and Globus Medical, Inc. (the “Parent”).
BOND HEDGE AMENDMENT LETTER AGREEMENTBond Hedge Amendment Letter Agreement • November 7th, 2023 • Globus Medical Inc • Surgical & medical instruments & apparatus • New York
THIS BOND HEDGE AMENDMENT LETTER AGREEMENT (this “Letter Agreement”), dated as of September 1, 2023, is entered into among Barclays Bank PLC (the “Dealer”), through its agent Barclays Capital Inc. (“Agent”), NuVasive, Inc. (the “Counterparty”) and Globus Medical, Inc. (the “Parent”).
